Andrew Obenshain, President and CEO at bluebird bio, Inc. (BLUE), sold 86 shares at $7.39 ($636) on 2025-02-03, disclosed to the SEC on 2025-02-05.
Seasonal sale ($636) by President and CEO — this insider has traded BLUE in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| BLUE | SELL | 2024-12-12 | $408 | — | Filing → |
| BLUE | SELL | 2024-10-02 | $18K | — | Filing → |
| BLUE | SELL | 2024-03-05 | $9K | — | Filing → |